ASTRAZEN6,843.00

AstraZeneca Pharma India Limited

· Pharma & Health
₹ CrorePeersSANOFICONRPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCMcap ₹17,108 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation14.940.028.6
+ Impairment Loss / (Reversal)0.00.50.0
+ Finance Costs1.21.54.5
+ Interest Income0.0-31.60.0
+ Share-based Payments2.75.11.1
+ Unrealised FX (Gain) / Loss0.2-0.7-1.0
+ Other Non-cash Items6.562.023.8
+ Other — Cash Effects are Investing / Financing0.0-0.30.0
Changes in Working Capital
+ Inventories-37.7-320.6-478.8
+ Trade Receivables — Current-51.2-31.7-45.8
+ Other Financial Assets — Current-4.4-5.30.0
+ Other Financial Assets — Non-current-1.20.0-1.4
+ Other Current Assets-1.2-28.322.4
+ Trade Payables — Current-31.4259.8326.4
+ Other Financial Liabilities — Current-1.6-6.8-4.2
+ Other Financial Liabilities — Non-current-0.40.00.0
+ Other Current Liabilities0.029.316.0
+ Provisions — Current0.90.3-52.3
Cash from Operating Activities
Profit Before Tax (per I/S)219.5156.4252.2228.3
+ Total Adjustments (incl. Working Capital)-102.7-26.8-160.8
Cash from Operations (pre-tax)116.9129.691.4
+ Interest Received — Operating32.10.0-23.2
+ Income Taxes Paid56.464.283.3
Cash from Operating Activities92.565.4-15.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.81.83.6
+ Disp of Fixed Assets0.40.70.3
+ Interest Received — Investing32.131.822.0
Cash from Investing Activities21.730.818.7
Cash from Financing Activities
+ Payment of Lease Liabilities0.05.57.5
+ Payment of Finance Lease Liabilities3.9
+ Interest Paid0.50.14.5
+ Dividends Paid40.060.080.0
Cash from Financing Activities-44.4-65.6-92.0
Net Changes in Cash (pre-FX)69.930.6-88.4
Net Changes in Cash69.930.6-88.4
Closing Cash69.9
Reference Items
EBITDA184.4254.0262.0229.9
EBITDA Margin %14.2414.8011.519.45
Free Cash Flow (CFO − Capex)81.863.6-18.8-18.8
Free Cash Flow to Equity63.6-23.2
Free Cash Flow per Basic Share32.7125.44-7.50-7.50
Cash Flow to Net Income0.570.56-0.08
Cash Paid for Taxes56.464.283.3
Cash Paid for Interest0.50.14.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.